Metformin prevents murine ovarian aging
Related Experiment Video
Updated: Jan 23, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Xian Qin1,2, Dingfu Du1, Qian Chen1
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
Abstract:
A number of studies have shown that metformin can delay aging process and extend healthy lifespan in animals. However, its role in female reproductive lifespan is unclear. This study was aimed to explore the potential anti-aging effect of metformin on the ovary and its possible mechanisms. Female C57BL/6 mice of 27-week old were divided into two groups, the control group (CON) and metformin-treated group (MET). CON mice were fed ad libitum, while MET mice were fed on chows supplied with 100mg/kg metformin for half a year. Ovarian reserve and function were assessed by ovarian follicle counts, estrous cycle and sex hormones levels. The expressions of oxidized metabolites, such as 8-hydroxy-2´-deoxyguanosine (8-OHdG), 4-hydroxynonenal (4-HNE), nitrotyrosine (NTY), and ovarian aging associated proteins P16, SIRT1, p-rpS6 and Bcl2 were examined. The MET mice exhibited increased level of serum E2 hormone and higher percentage of regular estrous cycles after 6 months' feeding, compared to the CON mice. The amount of primordial and primary follicles and the expression of SIRT1 were significantly increased, but the levels of P16, 8-OHdG, 4-HNE and p-rpS6 were decreased in the MET mice. These results indicate that metformin can delay ovarian aging process, probably by inducing the expression of SIRT1 and reducing the oxidative damage.
Insights
Metformin treatment improved female reproductive lifespan in mice by enhancing ovarian function and delaying aging. This study shows metformin delays ovarian aging, likely by increasing SIRT1 expression and reducing oxidative damage.
Area of Science:
- Reproductive biology
- Gerontology
- Pharmacology
Background:
- Metformin is known to delay aging and extend lifespan in animals.
- Its specific effects on female reproductive lifespan, particularly ovarian aging, remain unclear.
Purpose of the Study:
- To investigate the anti-aging effects of metformin on the ovary.
- To elucidate the underlying mechanisms of metformin's action on ovarian aging.
Main Methods:
- Female C57BL/6 mice were divided into control and metformin-treated groups for six months.
- Ovarian reserve, estrous cycle, hormone levels, and expression of aging markers (P16, SIRT1, oxidative metabolites) were assessed.
Main Results:
- Metformin-treated mice showed improved estrous cycle regularity and increased serum E2 hormone levels.
- Significant increases in primordial/primary follicles and SIRT1 expression were observed.
- Decreased levels of aging markers (P16) and oxidative damage indicators (8-OHdG, 4-HNE) were noted.
Conclusions:
- Metformin effectively delays ovarian aging in mice.
- The mechanism likely involves upregulation of SIRT1 and reduction of oxidative stress.
Related Concept Videos
Cancer Prevention
Some...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Ovarian Cycle
Prevention of Further Absorption of Poison
Preventive Healthcare Services
The Effect of Aging on Tissues

